These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8915698)

  • 1. Cimetidine in the treatment of porphyria cutanea tarda.
    Horie Y; Tanaka K; Okano J; Ohgi N; Kawasaki H; Yamamoto S; Kondo M; Sassa S
    Intern Med; 1996 Sep; 35(9):717-9. PubMed ID: 8915698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment for porphyria cutanea tarda with oral cimetidine.
    Fujita Y; Sato-Matsumura KC
    J Dermatol; 2010 Jul; 37(7):677-9. PubMed ID: 20629837
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
    To-Figueras J; Ozalla D; Mateu CH
    Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
    Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
    Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver.
    Freesemann A; Frank M; Sieg I; Doss MO
    Skin Pharmacol; 1995; 8(3):156-61. PubMed ID: 7632437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual porphyria of coexisting variegata and cutanea tarda.
    Sieg I; Bhutani LK; Doss MO
    Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):405-10. PubMed ID: 7548446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
    Okano J; Horie Y; Kawasaki H; Kondo M
    Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of porphyria cutanea tarda with oral thalidomide.
    Monastirli A; Georgiou S; Bolsen K; Pasmatzi E; Papapanagiotou A; Goerz G; Kalofoutis A; Merk HF; Tsambaos D
    Skin Pharmacol Appl Skin Physiol; 1999; 12(6):305-11. PubMed ID: 10545826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Treatment Using Cimetidine for Erythropoietic Protoporphyria in Children.
    Tu JH; Sheu SL; Teng JM
    JAMA Dermatol; 2016 Nov; 152(11):1258-1261. PubMed ID: 27410690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A first report of porphyria cutanea tarda successfully treated with glycyrrhizin.
    Li Y; Yu N; Han D; Ding Y; Xu Y
    Dermatol Ther; 2019 Sep; 32(5):e13014. PubMed ID: 31269308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary porphyrin concentration in porphyria cutanea tarda.
    Moran MJ; Santos JL; Fontanellas A; Sepulveda P; Enriquez de Salamanca R
    J Dermatol Sci; 1993 Oct; 6(2):155-8. PubMed ID: 7903863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels.
    Furuta M; Kaito M; Gabazza E; Fujita N; Ishida S; Tamaki S; Ikeda R; Wakisawa S; Hayashi H; Watanabe S; Adachi Y
    J Gastroenterol; 2000; 35(1):60-2. PubMed ID: 10632544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
    Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
    Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload.
    Valls V; Ena J; Enríquez-De-Salamanca R
    J Dermatol Sci; 1994 Jun; 7(3):169-75. PubMed ID: 7918235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of porphyrin-excretion in female estrogen-induced porphyria cutanea tarda.
    Enríquez de Salamanca R; Mingo D; Chinarro S; Muñoz JJ; Perpiñá J
    Arch Dermatol Res; 1982; 274(1-2):179-84. PubMed ID: 7165364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of porphyrins in two cases of porphyria cutanea tarda during a period of various treatments.
    Eriksen L; Thune PO
    Scand J Clin Lab Invest; 1978 May; 38(3):273-7. PubMed ID: 307270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyrin fluorescence in plasma of various types of porphyria].
    Gregor A; Kostrzewska E; Tarczyńska-Nosal S; Stachurska H
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):284-6. PubMed ID: 7808953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.